We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Rules That a Drug’s API Doesn't Impact ‘U.S. Made’ Designation
Court Rules That a Drug’s API Doesn't Impact ‘U.S. Made’ Designation
Drug distributor Acetris Health prevailed yesterday in an appeals court ruling that the company can call its products U.S.-made even though the active pharmaceutical ingredients are sourced elsewhere.